氢化泼尼松琥珀酸钠结构式
|
常用名 | 氢化泼尼松琥珀酸钠 | 英文名 | Predonine |
|---|---|---|---|---|
| CAS号 | 1715-33-9 | 分子量 | 482.499 | |
| 密度 | N/A | 沸点 | 689.8ºC at 760mmHg | |
| 分子式 | C25H31NaO8 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 233.5ºC | |
| 符号 |
GHS07, GHS08 |
信号词 | Warning |
氢化泼尼松琥珀酸钠用途【用途一】 用作医药中间体 |
| 中文名 | 泼尼松龙琥珀酸钠 |
|---|---|
| 英文名 | Prednisolone 21-hemisuccinate sodium salt |
| 中文别名 | 氢化泼尼松琥珀酸钠 | 泼尼松龙21-半丁二酸钠 | 波尼松龙21-半琥珀酸钠盐 |
| 英文别名 | 更多 |
| 沸点 | 689.8ºC at 760mmHg |
|---|---|
| 分子式 | C25H31NaO8 |
| 分子量 | 482.499 |
| 闪点 | 233.5ºC |
| 精确质量 | 482.191650 |
| PSA | 141.03000 |
| LogP | 0.63860 |
| InChIKey | BKKKAAMXMKMGER-CODXZCKSSA-N |
| SMILES | CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O.[Na] |
| 外观性状 | powder | white |
| 蒸汽压 | 5.08E-22mmHg at 25°C |
| 储存条件 | -20°C密封储存 |
| 稳定性 | 常温常压下稳定 |
| 计算化学 | 1、 氢键供体数量:3 2、 氢键受体数量:8 3、 可旋转化学键数量:7 4、 互变异构体数量:6 5、 拓扑分子极性表面积(TPSA):138 6、 重原子数量:34 7、 表面电荷:1 8、 复杂度:950 9、 同位素原子数量:0 10、 确定原子立构中心数量:7 11、 不确定原子立构中心数量:0 12、 确定化学键立构中心数量:0 13、 不确定化学键立构中心数量:0 14、 共价键单元数量:2 |
| 更多 | 1. 性状:白色粉末。 2. 密度(g/mL,25/4℃): 未确定 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(ºC):未确定 5. 沸点(ºC,常压):未确定 6. 沸点(ºC,5.2kPa): 未确定 7. 折射率: 未确定 8. 闪点(ºC): 未确定 9. 比旋光度(º): 未确定 10. 自燃点或引燃温度(ºC): 未确定 11. 蒸气压(kPa,25ºC): 未确定 12. 饱和蒸气压(kPa,60ºC): 未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC): 未确定 15. 临界压力(KPa): 未确定 16. 油水(辛醇/水)分配系数的对数值: 未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V): 未确定 19. 溶解性:未确定 |
| 符号 |
GHS07, GHS08 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H302-H351 |
| 警示性声明 | P281 |
| 个人防护装备 | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| 危害码 (欧洲) | Xn: Harmful; |
| 风险声明 (欧洲) | R22 |
| 安全声明 (欧洲) | S22-S36 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |
| RTECS号 | TU4153500 |
|
Immediate-type hypersensitivity to succinylated corticosteroids.
Int. Arch. Allergy Immunol. 155(1) , 86-92, (2011) Despite their frequent use, systemic corticosteroids have rarely elicited immediate-type reactions.We report two male patients, aged 26 and 70 years, respectively, with severe immediate-type hypersens... |
|
|
Impairment of angiogenic activity in the serum from patients with coronary aneurysms due to Kawasaki disease.
Circ. J. 71(7) , 1052-9, (2007) The inflammatory mediators play an important role in the progression of coronary vasculitis in Kawasaki disease (KD), but effects of KD serum including inflammatory mediators on endothelial cells rema... |
|
|
Influence of glucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry.
Mod. Rheumatol. 18(6) , 552-61, (2008) The influence of glucocorticoid (GC) on bone in rats at different ages was investigated in order to provide insight into human glucocorticoid induced osteoporosis (GCOP). Three-, 6-, and 12-month-old ... |
|
实验名称:Primary cell-based high-throughput screening assay for identification of compounds th...
来源:Johns Hopkins Ion Channel Center
靶标:regulator of G-protein signaling 4 isoform 2 [Homo sapiens]
External Id:JHICC_RGS_Act_HTS
|
|
实验名称:Luminescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:mu-type opioid receptor isoform MOR-1 [Homo sapiens]
External Id:OPRM1-OPRD1_AG_LUMI_1536_1X%ACT PRUN
|
|
实验名称:QFRET-based biochemical primary high throughput screening assay to identify exosite i...
来源:The Scripps Research Institute Molecular Screening Center
靶标:disintegrin and metalloproteinase domain-containing protein 17 preproprotein [Homo sapiens]
External Id:ADAM17_INH_QFRET_1536_1X%INH PRUN
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:uHTS identification of small molecule activators of the adaptive arm of the Unfolded ...
来源:Burnham Center for Chemical Genomics
靶标:N/A
External Id:BCCG-A405-UPR-XBP1-PrimaryAgonist-Assay
|
|
实验名称:Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020);...
来源:ChEMBL
靶标:Staphylococcus aureus
External Id:CHEMBL4296184
|
|
实验名称:Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); ...
来源:ChEMBL
靶标:Klebsiella pneumoniae
External Id:CHEMBL4296186
|
|
实验名称:Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CA...
来源:ChEMBL
靶标:Escherichia coli
External Id:CHEMBL4296185
|
|
实验名称:A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS979
|
|
实验名称:High throughput fluorescence intensity-based biochemical assay to screen for small mo...
来源:University of Pittsburgh Molecular Library Screening Center
靶标:furin (paired basic amino acid cleaving enzyme), isoform CRA_a [Homo sapiens]
External Id:MH080376 Biochemical HTS for Inhibitors of the Proprotein Convertase Furin.
|
| Solu-Decortin |
| Meticortelane |
| MFCD00070045 |
| Prednisolone 21-succinate sodium salt |
| EINECS 216-995-1 |
| Sodium 4-{[(11β)-11,17-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl]oxy}-4-oxobutanoate |
| butanedioic acid, mono[(11β)-11,17-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl] ester, monosodium salt |
| Predonine |
| METICORTELONE |
| 11β,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(sodium succinate) |
| Butanedioic acid, mono[(11β)-11,17-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl] ester, sodium salt (1:1) |
| Prednisolone 21-succinate sodium |
| 11b,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(Sodium Succinate) |
| Prednisolone sodium succinate |